康诺思腾完成约2亿美元超募融资 获港投公司领投

Core Insights - The company 康诺思腾 has completed a new funding round, raising approximately $200 million, which will be primarily used to accelerate commercialization and support the development and clinical registration of next-generation products [1] Funding Details - The recent funding round included investments from Hong Kong Investment Management Limited, a global strategic investor, and a top sovereign wealth fund [1] - Continued support was received from existing investors such as Qiming Venture Partners, Daohe Investment, and Gao Rong Capital [1]